Idexx Laboratories has announced the appointment of Stuart Essig as a member of its board of directors, increasing its number of board members from eight to nine.
Dr Essig has served as chairman of the board at Integra LifeSciences since 2012, having previously been employed as chief executive officer from 1997 until 2012. During this time, he has been credited with building Integra into a leading global surgical products company.
“Idexx Laboratories has appointed Integra LifeSciences chairman Stuart Essig as the newest member of its board of directors.“
He is also the current managing director of the private investment firm Prettybrook Partners, the chairman of the board of the medical technology firm Breg, and a member of the boards of SeaSpine, and Owens and Minor.
As such, Dr Essig can offer extensive executive management experience and deep strategic expertise accrued across numerous global healthcare industry roles, which will help Idexx to achieve strong organic growth.
Jonathan Ayers, the company's chairman and chief executive officer, said: "Stuart's perspective and insight will further strengthen our board's already broad and diverse capabilities and experiences and be extremely valuable to Idexx as we continue our growth trajectory as a global leader in pet healthcare innovation."
With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Animal Health